This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Comparing Opiant Pharmaceuticals' OPNT003 with Emergent Biosolutions' Narcan in the opioid reversal agent landscape

Ticker(s): OPNT, EBS

Who's the expert?

Institution: Spokane Fire Department

  • Chief of City of Spokane Fire Department.
  • Expertise in Naloxone and EMS services.
  • 30 years of experience spans primarily three states (MO, KS, and WA) as a Paramedic/Firefighter, Flight Paramedic, Chief Officer, incident commander, emergency services instructor, hazardous materials team specialist, and wildland firefighter.

Interview Goal
This conversation will focus on the use of Narcan as an opioid reversal agent and where OPNT003 could fit in.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.